F-group (family)
2003.1.8.4 MurD-like_N
Ligands and drugs
400
Member domains
31
with ligand contacts (≤ 4 Å)
7.8% of members
23
with DrugDomain annotations
5.8% of members
18
with a DrugBank compound
4.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.8.4 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01673 | UMA | Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine | 7 |
| DB02314 | UAG | Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate | 1 |
| DB08105 | LK1 | N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid | 1 |
| DB08106 | LK2 | N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid | 1 |
| DB08107 | LK3 | N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID | 1 |
| DB08108 | LK4 | N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID | 1 |
| DB08112 | LKM | N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| UMA | URIDINE-5'-DIPHOSPHATE-N-ACETYLMURAMOYL-L-ALANINE | 10 |
| CL | CHLORIDE ION | 6 |
| CAmetal | CALCIUM ION | 3 |
| SO3 | SULFITE ION | 2 |
| 051 | (1R,3R,4S)-4-[({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)AMINO]CYCLOHEXANE-1,3-DICARBOXYLIC ACID | 1 |
| D17 | N-({3-[({4-[(Z)-(4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl}amino)methyl]phenyl}carbonyl)-L-glutamic acid | 1 |
| IK4 | N-({7-[(4-cyanobenzyl)oxy]naphthalen-2-yl}sulfonyl)-D-glutamic acid | 1 |
| LK1 | N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-L-GLUTAMIC ACID | 1 |
| LK2 | N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-D-GLUTAMIC ACID | 1 |
| LK3 | N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID | 1 |
| LK4 | N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID | 1 |
| LKM | N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID | 1 |
| MGmetal | MAGNESIUM ION | 1 |
| N04 | (2R)-2-[[3-[[3-[(Z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenoxy]methyl]phenyl]carbonylamino]pentanedioic acid | 1 |
| N21 | (2R)-2-[[4-[[4-[(Z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenoxy]methyl]phenyl]sulfonylamino]pentanedioic acid | 1 |
| NAmetal | SODIUM ION | 1 |
| T04 | 2-[[2-fluoro-5-[[[4-[(Z)-(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]phenyl]amino]methyl]phenyl]carbonylamino]pentanedioic acid | 1 |
| T26 | (2R)-2-[[3-[[4-[(Z)-(4-OXO-2-SULFANYLIDENE-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]PHENYL]METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID | 1 |
| UAG | URIDINE-5'-DIPHOSPHATE-N-ACETYLMURAMOYL-L-ALANINE-D-GLUTAMATE | 1 |
| VSV | N-({3-[({4-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]PHENYL}AMINO)METHYL]PHENYL}CARBONYL)-D-GLUTAMIC ACID | 1 |